MapLight Therapeutics Statistics
Total Valuation
MPLT has a market cap or net worth of $1.30 billion. The enterprise value is $998.26 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MPLT has 45.35 million shares outstanding. The number of shares has increased by 2,509.30% in one year.
| Current Share Class | 42.62M |
| Shares Outstanding | 45.35M |
| Shares Change (YoY) | +2,509.30% |
| Shares Change (QoQ) | +40.83% |
| Owned by Insiders (%) | 6.01% |
| Owned by Institutions (%) | 37.06% |
| Float | 12.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.25 |
| P/TBV Ratio | 3.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 22.91, with a Debt / Equity ratio of 0.01.
| Current Ratio | 22.91 |
| Quick Ratio | 21.71 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -80.95% and return on invested capital (ROIC) is -52.01%.
| Return on Equity (ROE) | -80.95% |
| Return on Assets (ROA) | -49.51% |
| Return on Invested Capital (ROIC) | -52.01% |
| Return on Capital Employed (ROCE) | -51.93% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.50M |
| Employee Count | 133 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 24.65 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 52.29 |
| Average Volume (20 Days) | 312,716 |
Short Selling Information
The latest short interest is 1.74 million, so 3.85% of the outstanding shares have been sold short.
| Short Interest | 1.74M |
| Short Previous Month | 1.68M |
| Short % of Shares Out | 3.85% |
| Short % of Float | 14.11% |
| Short Ratio (days to cover) | 5.38 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -210.04M |
| Pretax Income | -199.48M |
| Net Income | -199.48M |
| EBITDA | -209.47M |
| EBIT | -210.04M |
| Earnings Per Share (EPS) | -$10.07 |
Full Income Statement Balance Sheet
The company has $310.11 million in cash and $5.59 million in debt, with a net cash position of $304.52 million or $6.72 per share.
| Cash & Cash Equivalents | 310.11M |
| Total Debt | 5.59M |
| Net Cash | 304.52M |
| Net Cash Per Share | $6.72 |
| Equity (Book Value) | 399.83M |
| Book Value Per Share | 8.84 |
| Working Capital | 312.95M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$163.77 million and capital expenditures -$497,000, giving a free cash flow of -$164.26 million.
| Operating Cash Flow | -163.77M |
| Capital Expenditures | -497,000 |
| Depreciation & Amortization | 574,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -164.26M |
| FCF Per Share | -$3.62 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MPLT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,509.30% |
| Shareholder Yield | -2,509.30% |
| Earnings Yield | -15.31% |
| FCF Yield | -12.61% |
Analyst Forecast
The average price target for MPLT is $34.43, which is 19.84% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.43 |
| Price Target Difference | 19.84% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |